DE69839875D1 - Zusammensetzung enthaltend auf festen Teilchen immobilisierte Radioisotopen, sowie deren Verwendung in der Brachytherapie - Google Patents

Zusammensetzung enthaltend auf festen Teilchen immobilisierte Radioisotopen, sowie deren Verwendung in der Brachytherapie

Info

Publication number
DE69839875D1
DE69839875D1 DE69839875T DE69839875T DE69839875D1 DE 69839875 D1 DE69839875 D1 DE 69839875D1 DE 69839875 T DE69839875 T DE 69839875T DE 69839875 T DE69839875 T DE 69839875T DE 69839875 D1 DE69839875 D1 DE 69839875D1
Authority
DE
Germany
Prior art keywords
solid particles
immobilized
brachytherapy
composition containing
containing radioisotopes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69839875T
Other languages
English (en)
Inventor
Antioco Franco Sedda
Mariana Adamo
Gabriele Rossi
Cesidio Cipriani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agenzia Nazionale per le Nuove Tecnologie lEnergia e lo Sviluppo Economico Sostenibile ENEA
Original Assignee
Agenzia Nazionale per le Nuove Tecnologie lEnergia e lo Sviluppo Economico Sostenibile ENEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agenzia Nazionale per le Nuove Tecnologie lEnergia e lo Sviluppo Economico Sostenibile ENEA filed Critical Agenzia Nazionale per le Nuove Tecnologie lEnergia e lo Sviluppo Economico Sostenibile ENEA
Application granted granted Critical
Publication of DE69839875D1 publication Critical patent/DE69839875D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1213—Semi-solid forms, gels, hydrogels, ointments, fats and waxes that are solid at room temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A61K51/1251—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE69839875T 1998-05-11 1998-12-23 Zusammensetzung enthaltend auf festen Teilchen immobilisierte Radioisotopen, sowie deren Verwendung in der Brachytherapie Expired - Fee Related DE69839875D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98RM000303A IT1299175B1 (it) 1998-05-11 1998-05-11 Composizione contenente radioisotopi immobilizzati su particelle solide, utile in particolare per la brachiterapia clinica in patologie

Publications (1)

Publication Number Publication Date
DE69839875D1 true DE69839875D1 (de) 2008-09-25

Family

ID=11405917

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69839875T Expired - Fee Related DE69839875D1 (de) 1998-05-11 1998-12-23 Zusammensetzung enthaltend auf festen Teilchen immobilisierte Radioisotopen, sowie deren Verwendung in der Brachytherapie

Country Status (4)

Country Link
EP (1) EP0979656B1 (de)
AT (1) ATE404226T1 (de)
DE (1) DE69839875D1 (de)
IT (1) IT1299175B1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007008232A2 (en) 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
JP2009513696A (ja) * 2005-11-01 2009-04-02 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム 内部局所放射線治療用生物分解可能な複合体
US9855445B2 (en) 2016-04-01 2018-01-02 Varian Medical Systems, Inc. Radiation therapy systems and methods for delivering doses to a target volume
US10549117B2 (en) 2017-07-21 2020-02-04 Varian Medical Systems, Inc Geometric aspects of radiation therapy planning and treatment
US11590364B2 (en) 2017-07-21 2023-02-28 Varian Medical Systems International Ag Material inserts for radiation therapy
US10183179B1 (en) 2017-07-21 2019-01-22 Varian Medical Systems, Inc. Triggered treatment systems and methods
US10843011B2 (en) 2017-07-21 2020-11-24 Varian Medical Systems, Inc. Particle beam gun control systems and methods
US11712579B2 (en) 2017-07-21 2023-08-01 Varian Medical Systems, Inc. Range compensators for radiation therapy
US10092774B1 (en) 2017-07-21 2018-10-09 Varian Medical Systems International, AG Dose aspects of radiation therapy planning and treatment
EP3967367A1 (de) 2017-11-16 2022-03-16 Varian Medical Systems Inc Erhöhte strahlausgabe und dynamische feldformung für strahlentherapiesystem
US10910188B2 (en) 2018-07-25 2021-02-02 Varian Medical Systems, Inc. Radiation anode target systems and methods
US11116995B2 (en) 2019-03-06 2021-09-14 Varian Medical Systems, Inc. Radiation treatment planning based on dose rate
US10814144B2 (en) 2019-03-06 2020-10-27 Varian Medical Systems, Inc. Radiation treatment based on dose rate
US11090508B2 (en) 2019-03-08 2021-08-17 Varian Medical Systems Particle Therapy Gmbh & Co. Kg System and method for biological treatment planning and decision support
US11103727B2 (en) 2019-03-08 2021-08-31 Varian Medical Systems International Ag Model based PBS optimization for flash therapy treatment planning and oncology information system
US10918886B2 (en) 2019-06-10 2021-02-16 Varian Medical Systems, Inc. Flash therapy treatment planning and oncology information system having dose rate prescription and dose rate mapping
US11291859B2 (en) 2019-10-03 2022-04-05 Varian Medical Systems, Inc. Radiation treatment planning for delivering high dose rates to spots in a target
US11865361B2 (en) 2020-04-03 2024-01-09 Varian Medical Systems, Inc. System and method for scanning pattern optimization for flash therapy treatment planning
US11541252B2 (en) 2020-06-23 2023-01-03 Varian Medical Systems, Inc. Defining dose rate for pencil beam scanning
US11957934B2 (en) 2020-07-01 2024-04-16 Siemens Healthineers International Ag Methods and systems using modeling of crystalline materials for spot placement for radiation therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE444989B (sv) * 1979-12-17 1986-05-20 Jan Ivan Thorell Reagenskomposition for radioimmunologiska bestemningsmetoder
US5061475A (en) * 1985-06-07 1991-10-29 Cadema Medical Products, Inc. Composition and method of treatment of arthritis and related diseases with holmium-166 radionuclides
US5362473A (en) * 1988-10-14 1994-11-08 Mallinckrodt Medical, Inc. Radiolabelled particulate composition
JPH06218276A (ja) * 1993-01-27 1994-08-09 Mitsui Toatsu Chem Inc 安定化された金属酸化物超微粒子とその製造方法
WO1997049335A1 (en) * 1996-06-24 1997-12-31 The Dupont Merck Pharmaceutical Company Novel radiopharmaceutical compositions and matrices and uses thereof

Also Published As

Publication number Publication date
ITRM980303A1 (it) 1999-11-11
ITRM980303A0 (it) 1998-05-11
EP0979656A3 (de) 2004-03-03
EP0979656A2 (de) 2000-02-16
EP0979656B1 (de) 2008-08-13
IT1299175B1 (it) 2000-02-29
ATE404226T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
DE69839875D1 (de) Zusammensetzung enthaltend auf festen Teilchen immobilisierte Radioisotopen, sowie deren Verwendung in der Brachytherapie
MY121548A (en) Compounds and methods for the treatment of cancer
DE69738918D1 (de) Lipoxinverbindungen und deren Verwendung zur Behandlung der Zellenwucherungsstörung
BR9915080A (pt) Fonte radioativa para uso em braquiterapia, métodos para a preparação de uma fonte radioativa e para tratamento de uma condição que responde à terapia de radiação, e, composição
DE69830072D1 (de) Radioaktive zusammensetzungen zur behandlung von prostatatumoren
TW200728465A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
DK96588A (da) Antitumirmiddel indeholdende makromolekylaere platinforbindelser
DE93619T1 (de) Plasminogenaktivator fuer menschliches gewebe, diesen aktivator enthaltende pharmazeutische zusammensetzungen, verfahren zur herstellung des aktivators sowie dna und transformierte zellzwischenprodukte hierfuer.
DE69826711D1 (de) Verfahren zur behandlung von pigmentierten krebszellen durch photodynamische therapie
AR012626A1 (es) Una composicion farmaeutica que comprende un derivado o análogo de leptina como inhibidor de la proliferacion de células de tumor y el uso de dicha composicion farmaceutica para la manufactura de medicamento para el tratamiento de tumores
DE3376295D1 (en) Pharmaceutical composition containing adenosine derivatives for use in treating tumours
FI940375A (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
BR9809495A (pt) "maleimidas aromáticas e métodos para seus usos"
AU7655300A (en) Radiation source for endovascular radiation treatment in form of a wire
DK0951553T3 (da) Adenovirus-E4-proteiner til induktion af celledød
DK0730871T3 (da) Radioaktivt kompleks og anvendelsen heraf til strålebehandling
EP0716614A4 (de) Behandlung von menschlichen tumoren durch genetische transformation von menschlichen tumorzellen
DK0768886T3 (da) Endothelforingseffekter og behandling af vasospastiske lidelser
PT81093B (pt) Processo para a preparacao de uma composicao terapeutica para tratamento de um tumor
ATE159171T1 (de) Arzneimittelzusammensetzung enthaltend tcf-ii
DK0697875T3 (da) Anvendelse af modificerede TALL-104 celler til behandling af cancer og virale sygdomme
ATE334686T1 (de) Sphingomyelin enthaltende zusammensetzung zur verbesserung der tumortherapie
DK484685D0 (da) Micellulaere partikelkompositioner til maalrettet tilfoersel til tumorer i mennesker og kompositionernes anvendelse
AU3319184A (en) Enhancing the acceptance of transplanted organ/tissue by UV radiation
ZA885625B (en) Therapeutic agents containing enantiomers of propafenone

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee